News

The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, freeze dried vaccine composition that uses conventional adjuvants comprised of aluminum salts, in addition to claims covering

R-Tech is trialing RU-101 ophthalmic solution as a severe dry eye therapy. Novozymes Biopharma marketing director Dermot Pearson said, "Novozymes is dedicated to supporting our customers in the

Focused on advancing the proprietary diagnostic technology, originally developed by Lilly, the collaboration agreement is part of Corgenix’ expanded contract services business unit for the healthcare and biotechnology

The company submitted a biologics license application (BLA) to the FDA for its pegylated subcutaneous injectable candidate developed for relapsing forms of multiple sclerosis. The BLA application included

Development of the new antibiotics will receive funding through a public-private partnership. For the initial period of 18 months, HHS will provide $40m and around $200m upon the

Analyzing human genetic changes will also help in identifying chromosomal abnormalities that cause conditions such as bipolar disorder and schizophrenia. The research partnership, which received $1.8m grant from

The company, which operates in consumer, pharmaceutical and medical devices, and diagnostics segments, has not disclosed the decision so far, as reported by pakistantoday.com. Meanwhile, Johnson & Johnson

In its inspection, the federal agency found that the company violated current Good Manufacturing Practice (cGMP) for the manufacture of APIs and the cGMP regulations for finished pharmaceuticals,

As part of the MoU, BTI will team up Glyco-MEV laboratory and Agilent to develop new analytical tools and techniques to confirm the safety and effectiveness of these